Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
1983
174
Last FY Revenue $33.4M
Last FY EBITDA -$1.5M
$27.1M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Vimab Group achieved revenue of $33.4M and an EBITDA of -$1.5M.
Vimab Group expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Vimab Group valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $33.4M | XXX | XXX | XXX |
Gross Profit | XXX | $26.2M | XXX | XXX | XXX |
Gross Margin | XXX | 79% | XXX | XXX | XXX |
EBITDA | XXX | -$1.5M | XXX | XXX | XXX |
EBITDA Margin | XXX | -5% | XXX | XXX | XXX |
EBIT | XXX | -$8.2M | XXX | XXX | XXX |
EBIT Margin | XXX | -25% | XXX | XXX | XXX |
Net Profit | XXX | -$7.9M | XXX | XXX | XXX |
Net Margin | XXX | -24% | XXX | XXX | XXX |
Net Debt | XXX | $5.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Vimab Group's stock price is SEK 8 (or $1).
Vimab Group has current market cap of SEK 191M (or $19.7M), and EV of SEK 263M (or $27.1M).
See Vimab Group trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$27.1M | $19.7M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Vimab Group has market cap of $19.7M and EV of $27.1M.
Vimab Group's trades at 0.8x EV/Revenue multiple, and -17.6x EV/EBITDA.
Equity research analysts estimate Vimab Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Vimab Group's P/E ratio is not available.
See valuation multiples for Vimab Group and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $19.7M | XXX | $19.7M | XXX | XXX | XXX |
EV (current) | $27.1M | XXX | $27.1M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 0.8x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | -17.6x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -3.3x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -2.5x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -32.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialVimab Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Vimab Group's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Vimab Group's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Vimab Group and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | -5% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 103% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Almunda Professionals | XXX | XXX | XXX | XXX | XXX | XXX |
Appen | XXX | XXX | XXX | XXX | XXX | XXX |
RPMGlobal | XXX | XXX | XXX | XXX | XXX | XXX |
Bluebik Group | XXX | XXX | XXX | XXX | XXX | XXX |
Business Online | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Vimab Group acquired XXX companies to date.
Last acquisition by Vimab Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Vimab Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Vimab Group founded? | Vimab Group was founded in 1983. |
Where is Vimab Group headquartered? | Vimab Group is headquartered in Sweden. |
How many employees does Vimab Group have? | As of today, Vimab Group has 174 employees. |
Is Vimab Group publicy listed? | Yes, Vimab Group is a public company listed on STO. |
What is the stock symbol of Vimab Group? | Vimab Group trades under VIMAB ticker. |
When did Vimab Group go public? | Vimab Group went public in 2015. |
Who are competitors of Vimab Group? | Similar companies to Vimab Group include e.g. Almunda Professionals, Appen, RPMGlobal, Bluebik Group. |
What is the current market cap of Vimab Group? | Vimab Group's current market cap is $19.7M |
Is Vimab Group profitable? | Yes, Vimab Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.